Kidney cancer accounted for nearly 175,000 deaths worldwide in 2018 [1]}, and it is projected that 14,770 deaths will occur due to the disease in 2019 in the US [2]}. Current kidney tumor treatment planning include Radical Nephrectomy (RN) and Partial Nephrectomy (PN). In RN, both the tumor and the affected kidney are removed whereas in PN the tumor is removed but kidneys are saved [3]}. Although RNs were historically prevalent as a standard treatment procedure for kidney tumors, new capabilities for earlier detection of the tumors as well as advancements in surgery has made PNs a viable treatment approach [4]}.
